United Orthopedic Corporation (TPEX:4129)
Taiwan
· Delayed Price · Currency is TWD 105.00
0.00 (0.00%)
At close: Mar 9, 2026
United Orthopedic Revenue
United Orthopedic had revenue of 1.49B TWD in the quarter ending September 30, 2025, with 31.93% growth. This brings the company's revenue in the last twelve months to 5.46B, up 22.01% year-over-year. In the year 2024, United Orthopedic had annual revenue of 4.65B with 18.40% growth.
Revenue (ttm)
5.46B
Revenue Growth
+22.01%
P/S Ratio
1.86
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.65B | 723.24M | 18.40% |
| Dec 31, 2023 | 3.93B | 761.21M | 24.02% |
| Dec 31, 2022 | 3.17B | 597.81M | 23.25% |
| Dec 31, 2021 | 2.57B | 228.64M | 9.76% |
| Dec 31, 2020 | 2.34B | -94.47M | -3.88% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TaiDoc Technology | 4.34B |
| InnoCare Optoelectronics | 2.18B |
| Hi-Clearance | 4.19B |
| Delta Asia International | 711.19M |
| Bonraybio | 287.10M |
| WeLeader Biomedical | 1.11B |
| Medimaging Integrated Solution | 656.21M |
| A Plus Biotechnology | 825.52M |